OTC FILING WATCH · LIVEOfficial-source OTC filing intelligence
AUTOMATED SEC FILING DILIGENCE BRIEF
PUBLIC-RECORD DELIVERY

Cell Source, Inc.

CIK 0001569340Ticker CLCSSEC observed OTC

Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.

Open issuer dossier
Reporting & material events67

captured official filings

Registration & offering14

captured official filings

Ownership24

captured official filings

Governance0

captured official filings

WHAT THIS AUTOMATES

One evidence index instead of a manual filing hunt.

It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.

PROFESSIONAL DELIVERY LAYER

What teams can pay to automate next.

Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.

MACHINE-DETECTED FILING CHANGE RADAR

Public registration text delta

Comparing S-1/A filed 2014-09-23 with S-1/A filed 2014-10-24.

Earlier SEC filingLatest SEC filing
460latest comparable sentences
37new-text candidates
26prior-text candidates not found

Tracked-term count changes

Counts are navigation signals, not conclusions. Open both official filings to determine materiality.

  • proceeds25 → 22-3
  • shares83 → 81-2
  • offering17 → 16-1

Candidate disclosure excerpts

Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.

New in latest filing
  • PRELIMINARY PROSPECTUS, SUBJECT TO COMPLETION, DATED OCTOBER 24, 2014 CELL SOURCE, INC. 9,618,648 SHARES OF COMMON STOCK This prospectus relates to the sale of up to 9,618,648 shares of common stock of Cell Source, Inc. by the Selling Stockholders, including 4,859,324 outstanding shares and 4,759,324 shares issuable upon the exe
  • Our Veto-Cell immune system management technology is based on technologies patented, owned, and licensed to us by Research and Development Company Limited, Yeda Research and Development Limited, the commercial arm of Weizmann Institute of Science in Rehovot Israel ("Yeda").
  • We intend to use those proceeds for general corporate purposes. (1) Based upon the total number of issued and outstanding shares as of October 23, 2014.
Present in earlier filing, not found in latest
  • PRELIMINARY PROSPECTUS, SUBJECT TO COMPLETION, DATED SEPTEMBER 23, 2014 CELL SOURCE, INC. 9,618,648 SHARES OF COMMON STOCK This prospectus relates to the sale of up to 9,618,648 shares of common stock of Cell Source, Inc. by the Selling Stockholders, including 4,859,324 outstanding shares and 4,759,324 shares issuable upon the e
  • Our Veto-Cell immune system management technology is based on technologies patented, owned, and licensed to us by Research and Development Company Limited, an Israeli corporation ("Yeda"), The Company's corporate headquarters is located at 65 Yigal Alon Street, 23rd Floor, Tel Aviv 67433, Israel, and the telephone number at such
  • We intend to use those proceeds for general corporate purposes. (1) Based upon the total number of issued and outstanding shares as of September 19, 2014.

Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.

DOWNLOAD EDITION

Save a project-ready issuer record.

US$29 one time. No subscription and no account. You receive the current printable Evidence Snapshot in this browser immediately after verified payment.

  • Source-linked filing chronology and registration path
  • Machine-detected amendment and tracked-term change view
  • Official-source index for project-file archiving and downloadable CSV export

Secure checkout by PayPal.

AUTOMATED EVIDENCE SNAPSHOT

Save this source-linked record

Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.

Unlock download · US$29
OFFICIAL SEC SUBMISSIONS

Captured filing chronology

Open Evidence Snapshot →
  1. 10-Q
    Reporting & material eventsOpen SEC filing →
  2. 10-K
    Reporting & material eventsOpen SEC filing →
  3. 8-K
    Reporting & material eventsOpen SEC filing →
  4. 10-Q
    Reporting & material eventsOpen SEC filing →
  5. 10-Q
    Reporting & material eventsOpen SEC filing →
  6. 10-Q
    Reporting & material eventsOpen SEC filing →
  7. 10-K
    Reporting & material eventsOpen SEC filing →
  8. 8-K
    Reporting & material eventsOpen SEC filing →
  9. 10-Q
    Reporting & material eventsOpen SEC filing →
  10. 10-Q
    Reporting & material eventsOpen SEC filing →
  11. 10-Q
    Reporting & material eventsOpen SEC filing →
  12. 10-K
    Reporting & material eventsOpen SEC filing →
  13. 10-Q
    Reporting & material eventsOpen SEC filing →
  14. 10-Q
    Reporting & material eventsOpen SEC filing →
  15. 10-Q
    Reporting & material eventsOpen SEC filing →
  16. 8-K
    Reporting & material eventsOpen SEC filing →
  17. 8-K
    Reporting & material eventsOpen SEC filing →
  18. 3
    OwnershipOpen SEC filing →
  19. 10-K
    Reporting & material eventsOpen SEC filing →
  20. 8-K
    Reporting & material eventsOpen SEC filing →
  21. 10-Q
    Reporting & material eventsOpen SEC filing →
  22. 10-Q
    Reporting & material eventsOpen SEC filing →
  23. 4
    OwnershipOpen SEC filing →
  24. 4
    OwnershipOpen SEC filing →
  25. 4
    OwnershipOpen SEC filing →
  26. 4
    OwnershipOpen SEC filing →
  27. 4
    OwnershipOpen SEC filing →
  28. 4
    OwnershipOpen SEC filing →
  29. 4
    OwnershipOpen SEC filing →
  30. SC 13D
    OwnershipOpen SEC filing →
  31. 4
    OwnershipOpen SEC filing →
  32. 4
    OwnershipOpen SEC filing →
  33. 10-Q
    Reporting & material eventsOpen SEC filing →
  34. SC 13D
    OwnershipOpen SEC filing →
  35. 3
    OwnershipOpen SEC filing →
  36. 10-K
    Reporting & material eventsOpen SEC filing →
  37. 8-K
    Reporting & material eventsOpen SEC filing →
  38. SC 13G
    OwnershipOpen SEC filing →
  39. 3
    OwnershipOpen SEC filing →
  40. SC 13G
    OwnershipOpen SEC filing →
  41. 10-Q
    Reporting & material eventsOpen SEC filing →
  42. 10-Q
    Reporting & material eventsOpen SEC filing →
  43. 10-Q
    Reporting & material eventsOpen SEC filing →
  44. 10-K
    Reporting & material eventsOpen SEC filing →
  45. 10-Q
    Reporting & material eventsOpen SEC filing →
  46. 10-Q
    Reporting & material eventsOpen SEC filing →
  47. 10-K/A
    Reporting & material eventsOpen SEC filing →
  48. 10-Q
    Reporting & material eventsOpen SEC filing →
  49. 8-K
    Reporting & material eventsOpen SEC filing →
  50. 10-K
    Reporting & material eventsOpen SEC filing →
  51. 10-Q
    Reporting & material eventsOpen SEC filing →
  52. 10-Q
    Reporting & material eventsOpen SEC filing →
  53. 10-Q
    Reporting & material eventsOpen SEC filing →
  54. 10-Q
    Reporting & material eventsOpen SEC filing →
  55. 10-Q
    Reporting & material eventsOpen SEC filing →
  56. 10-Q
    Reporting & material eventsOpen SEC filing →
  57. 10-K
    Reporting & material eventsOpen SEC filing →
  58. 10-Q
    Reporting & material eventsOpen SEC filing →
  59. 10-Q
    Reporting & material eventsOpen SEC filing →
  60. 10-Q
    Reporting & material eventsOpen SEC filing →
Evidence boundary

Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.